Cargando…

Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer

Application of doxorubicin (Dox) for the treatment of cancer is restricted due to its severe side effects. We used combination strategy by combining doxorubicin (Dox) with withaferin A (WFA) to minimize the ill effects of Dox. Treatment of various epithelial ovarian cancer cell lines (A2780, A2780/C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fong, Miranda Y., Jin, Shunying, Rane, Madhavi, Singh, Raj K., Gupta, Ramesh, Kakar, Sham S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408484/ https://www.ncbi.nlm.nih.gov/pubmed/22860102 http://dx.doi.org/10.1371/journal.pone.0042265

Ejemplares similares

Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling
por: Straughn, Alex R., et al.
Publicado: (2019)

Withaferin A attenuates ovarian cancer-induced cardiac cachexia
por: Kelm, Natia Q., et al.
Publicado: (2020)

Withaferin A and Ovarian Cancer Antagonistically Regulate Skeletal Muscle Mass
por: Straughn, Alex R., et al.
Publicado: (2021)

Withaferin A: a potential therapeutic agent against COVID-19 infection
por: Straughn, Alex R., et al.
Publicado: (2020)

Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells
por: Kakar, Sham S., et al.
Publicado: (2017)

Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells
por: Kakar, Sham S., et al.
Publicado: (2020)

Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells
por: Kakar, Sham S., et al.
Publicado: (2014)

Ovarian cancer mouse models: a summary of current models and their limitations
por: Fong, Miranda Y, et al.
Publicado: (2009)

Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
por: Martirosyan, Anna, et al.
Publicado: (2010)

Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer
por: Fong, Miranda Y., et al.
Publicado: (2011)

Concomitant Inhibition of Cytoprotective Autophagy Augments the Efficacy of Withaferin A in Hepatocellular Carcinoma
por: Siddharth, Sumit, et al.
Publicado: (2019)

Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
por: Behl, Tapan, et al.
Publicado: (2020)

Tumorigenic potential of pituitary tumor transforming gene (PTTG) in vivo investigated using a transgenic mouse model, and effects of cross breeding with p53 (+/−) transgenic mice
por: Fong, Miranda Y, et al.
Publicado: (2012)

Withaferin A inhibits Epithelial to Mesenchymal Transition in Non-Small Cell Lung Cancer Cells
por: Kyakulaga, Al Hassan, et al.
Publicado: (2018)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Synergistic combinations of paclitaxel and withaferin A against human non-small cell lung cancer cells
por: Kyakulaga, Al Hassan, et al.
Publicado: (2020)

Doxorubicin metabolism moderately attributes to putative toxicity in prodigiosin/doxorubicin synergism in vitro cells
por: Lin, Shian-Ren, et al.
Publicado: (2020)

Welcome to Journal of Ovarian Research
por: Palomba, Stefano, et al.
Publicado: (2008)

Withaferin A Induces ROS-Mediated Paraptosis in Human Breast Cancer Cell-Lines MCF-7 and MDA-MB-231
por: Ghosh, Kamalini, et al.
Publicado: (2016)

Safety, toxicity and pharmacokinetic assessment of oral Withaferin-A in mice
por: Gupta, Saurabh Kumar, et al.
Publicado: (2022)

PTTG: an important target gene for ovarian cancer therapy
por: Panguluri, Siva Kumar, et al.
Publicado: (2008)

Withaferin-A Induces Apoptosis in Osteosarcoma U2OS Cell Line via Generation of ROS and Disruption of Mitochondrial Membrane Potential
por: Zhang, Hui-Liang, et al.
Publicado: (2017)

Journal of Ovarian Research reviewer acknowledgement 2012
por: Curiel, David T, et al.
Publicado: (2013)

Journal of ovarian research reviewer acknowledgement 2014
por: Kakar, Sham S, et al.
Publicado: (2015)

Journal of Ovarian Research reviewer acknowledgement 2015
por: Kakar, Sham S., et al.
Publicado: (2016)

Journal of Ovarian Research reviewer acknowledgement 2013
por: Kakar, Sham S, et al.
Publicado: (2014)

Withaferin A Associated Differential Regulation of Inflammatory Cytokines
por: Dubey, Seema, et al.
Publicado: (2018)

Evaluation of the geroprotective effects of withaferin A in Drosophila melanogaster
por: Koval, Liubov, et al.
Publicado: (2021)

Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity
por: Jiang, Jiangsong, et al.
Publicado: (2017)

Stem Cells in Ovarian Cancer and Potential Therapies
por: Zuber, Elena, et al.
Publicado: (2020)

Sestrins as a Therapeutic Bridge between ROS and Autophagy in Cancer
por: Sánchez-Álvarez, Miguel, et al.
Publicado: (2019)

Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors
por: Parte, Seema C., et al.
Publicado: (2018)

Exosomes: an overview of biogenesis, composition and role in ovarian cancer
por: Beach, Allison, et al.
Publicado: (2014)

Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer
por: Shah, Parag P, et al.
Publicado: (2009)

Verrucarin J inhibits ovarian cancer and targets cancer stem cells
por: Carter, Kelsey, et al.
Publicado: (2017)

Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
por: Yang, Huanjie, et al.
Publicado: (2012)

Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
por: Dutta, Rinku, et al.
Publicado: (2019)

Estimation of Withaferin-A by HPLC and standardization of the Ashwagandhadi lehyam formulation
por: Meena, Ajay Kumar, et al.
Publicado: (2021)

Withaferin A: From Ancient Remedy to Potential Drug Candidate
por: Sultana, Tahira, et al.
Publicado: (2021)

Evaluating anticancer properties of Withaferin A—a potent phytochemical
por: Atteeq, Maushma
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tug0f00i8q8pmsl7uoj9jf7a6b